Jianmin Pharmaceutical Group Co. Ltd Financials

Market Capitalization CN¥5.99 Billion as of July 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	15.10
Forward PE	9.20
Price to Sales TTM	CN¥1.63
Price to Book MRQ	CN¥2.70
Enterprise to Revenue	1.39
Enterprise to EBITDA	28.07

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	10.76%
Operating Margin	2.89%
Return on Assets TTM	2.53%
Return on Equity TTM	18.95%

Income Statement

Revenue TTM	CN¥3,976,852,480
Revenue per Share TTM	CN¥25.94
Quarterly Revenue Growth	-8.80%
Gross Profit TTM	CN¥1,701,380,352
EBITDA	CN¥490,723,717
Net Income to Common TTM	CN¥427,949,376
Diluted EPS TTM	CN¥2.79
Quarterly Earnings Growth YoY	-49.50%

Balance Sheet

Total Cash MRQ	CN¥1,057,892,800
Total Cash per Share MRQ	CN¥6.90
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	7.60
Current Ratio MRQ	1.57
Book Value per Share MRQ	CN¥15.61

Cash Flow

Operating Cash Flow TTM	CN¥206,281,040
Levered Free Cash Flow TTM	CN¥9,223,671

600976 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	153,399,008
Float Shares	108,736,598
Avg 10 Volume	1,084,584
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	32.96%
% Held by Institutions	13.89%

Stock Price Summary

Beta	0.72
Fifty Two Week Low	CN¥39.82
Fifty Two Week High	CN¥66.80
Fifty Two Week Change	-26.44%
Day 50 MA	CN¥42.79
Day 200 MA	CN¥48.76

Dividends and Splits

Forward Annual Dividend Rate	CN¥4.80
Forward Annual Dividend Yield	11.39%
Trailing Annual Dividend Rate	CN¥1.20
Trailing Annual Dividend Yield	2.85%
Payout Ratio	43.01%
Dividend Date
Ex Dividend Date	2024-04-26
Last Split Factor
Last Split Date	2006-07-12